BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15952414)

  • 1. Final height in a patient with Laron syndrome after long-term therapy with rhlGF-I and short-term therapy with LHRH-analogue and oxandrolone during puberty.
    Zucchini S; Scarano E; Baldazzi L; Mazzanti L; Pirazzoli P; Cacciari E
    J Endocrinol Invest; 2005 Mar; 28(3):274-9. PubMed ID: 15952414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N; Keller E; Landy H;
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth promotion by oxandrolone in a girl with short stature and early pubertal development treated with growth hormone and gonadotropin-releasing hormone-analogue. A case study.
    Hermanussen M
    Acta Paediatr; 1995 Oct; 84(10):1207-10. PubMed ID: 8563241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GH and GnRH analog treatment in children who enter puberty at short stature.
    Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Hibi I
    J Pediatr Endocrinol Metab; 1997; 10(6):623-8. PubMed ID: 9467133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial.
    Mericq MV; Eggers M; Avila A; Cutler GB; Cassorla F
    J Clin Endocrinol Metab; 2000 Feb; 85(2):569-73. PubMed ID: 10690857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anabolic steroid oxandrolone increases muscle mass in prepubertal boys with constitutional delay of growth.
    Papadimitriou A; Preece MA; Rolland-Cachera MF; Stanhope R
    J Pediatr Endocrinol Metab; 2001 Jun; 14(6):725-7. PubMed ID: 11453521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.
    Bareille P; Massarano AA; Stanhope R
    Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of GnRH analogue on height potential in patients with severe growth hormone insensitivity syndrome treated with IGF-I.
    El Kholy M; Elsedfy HH
    J Pediatr Endocrinol Metab; 2011; 24(11-12):983-8. PubMed ID: 22308852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of prolonged administration of an anabolic steroid (oxandrolone) on growth in boys with constitutionally delayed growth and puberty.
    Schroor EJ; van Weissenbruch MM; Knibbe P; Delemarre-van de Waal HA
    Eur J Pediatr; 1995 Dec; 154(12):953-7. PubMed ID: 8801102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term auxological and pubertal outcome of patients with hereditary insulin-like growth factor-I deficiency (Laron and growth hormone-gene deletion syndrome) treated with recombinant human insulin-like growth factor-I.
    Messina MF; Arrigo T; Valenzise M; Ghizzoni L; Caruso-Nicoletti M; Zucchini S; Chiabotto P; Crisafulli G; Zirilli G; De Luca F
    J Endocrinol Invest; 2011 Apr; 34(4):292-5. PubMed ID: 20543555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
    Pucarelli I; Segni M; Ortore M; Moretti A; Iannaccone R; Pasquino AM
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial.
    Gault EJ; Perry RJ; Cole TJ; Casey S; Paterson WF; Hindmarsh PC; Betts P; Dunger DB; Donaldson MD;
    BMJ; 2011 Apr; 342():d1980. PubMed ID: 21493672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial.
    Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J
    J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience.
    Klein KO; Barnes KM; Jones JV; Feuillan PP; Cutler GB
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4711-6. PubMed ID: 11600530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
    Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined GH and LHRH analog treatment in short children.
    Tanaka T; Satoh M; Hibi I
    Endocr J; 1996 Oct; 43 Suppl():S13-7. PubMed ID: 9076337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.